Related Experiment Video
Updated: Nov 29, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Vitamin D/VDR in Acute Kidney Injury: A Potential Therapeutic Target
Siqing Jiang1, Lihua Huang2, Wei Zhang1
1Department of Nephrology, Third Xiangya Hospital, Central South University, 138 Tongzipo Rd, Changsha, Hunan 410013, China.
Abstract:
Despite many strategies and parameters used in clinical practice, the incidence and mortality of acute kidney injury (AKI) are still high with poor prognosis. With the development of molecular biology, the role of vitamin D and vitamin D receptor (VDR) in AKI is drawing increasing attention. Accumulated researches have suggested that Vitamin D deficiency is a risk factor of both clinical and experimental AKI, and vitamin D/VDR could be a promising therapeutic target against AKI. However, more qualitative clinical researches are needed to provide stronger evidence for the clinical application of vitamin D and VDR agonists in the future. Issues like the route and dosage of administration also await more attention. The present review aims to summarize the current works on the role of vitamin D/VDR in AKI and provides some new insight on its therapeutic potential.
Insights
Vitamin D and its receptor (VDR) show therapeutic potential for acute kidney injury (AKI). Further clinical research is needed to confirm vitamin D/VDR agonists
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Acute kidney injury (AKI) presents high mortality and poor prognosis despite current treatments.
- Vitamin D and its receptor (VDR) are increasingly recognized for their role in kidney health and disease.
- Vitamin D deficiency is linked to increased risk and severity in both clinical and experimental AKI.
Purpose of the Study:
- To review current research on the role of vitamin D/VDR in AKI.
- To explore the therapeutic potential of vitamin D and VDR modulation for AKI.
- To identify areas for future clinical research and therapeutic development.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of existing data on vitamin D and VDR in AKI models and patients.
- Synthesis of findings regarding the mechanisms and clinical implications of vitamin D/VDR in AKI.
Main Results:
- Accumulated evidence suggests vitamin D/VDR plays a protective role in AKI.
- Vitamin D deficiency is a significant risk factor for AKI development and progression.
- Vitamin D/VDR pathways represent a promising therapeutic target for AKI management.
Conclusions:
- Vitamin D and VDR agonists hold potential as novel therapeutic strategies for AKI.
- Further high-quality clinical trials are essential to validate efficacy and determine optimal administration.
- Research is needed on appropriate dosage and delivery methods for vitamin D-based AKI therapies.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management

